Beijing Showby Pharmaceutical

Showby Pharmaceutical is a clinical-stage biopharmaceutical company based in Beijing, China, focused on the discovery and development of innovative small molecule drugs for inflammatory and autoimmune diseases. The company specializes in the development of selective kinase inhibitors, particularly targeting the JAK/STAT pathway and phosphodiesterase enzymes. Its lead programs include topical and oral formulations for dermatological conditions such as atopic dermatitis and psoriasis, as well as respiratory treatments for COPD. Showby aims to provide high-quality, affordable therapeutic alternatives to global blockbuster drugs through optimized molecular design.